Latest News - Phyton Biotech

Stay Updated on Latest Phyton Biotech News and Events

Events

Phyton Biotech to attend CPHI Milan

Phyton Biotech will be attending CPHI Milan from October 8-10, 2024. This Fall, CPHI Milan is celebrating its 35th year in uniting the pharma industry.

In The Press

Phyton shares new article published by iScience that demonstrates that QS-21 produced via plant cell culture for saponin-derived vaccine adjuvants can be commercially produced in a sustainable way

Phyton shares new article published by iScience that demonstrates that QS-21 produced via plant cell culture for saponin-derived vaccine adjuvants can be commercially produced in a sustainable way

Alex Assistant2024-03-15T09:24:37-08:00March 14th, 2024|

Phyton Biotech announces acquisition of Controlled Substances Dealers License from Health Canada

Phyton Biotech announces acquisition of Controlled Substances Dealers License from Health Canada

Alex Assistant2023-11-29T10:14:55-08:00November 29th, 2023|

Phyton Biotech to attend BIO-Europe 2023

Phyton Biotech to attend BIO-Europe 2023

Alex Assistant2023-11-01T18:26:50-08:00August 11th, 2023|

See All News Releases

Case Studies

Case Study: Using Green Chemistry to Produce Taxol

Case Study: Using Green Chemistry to Produce Taxol

Taxol® (manufactured by Bristol-Myers Squibb) is an important drug used to treat many types of solid tumor cancers and Kaposi’s sarcoma. It is on the World Health Organization’s List of Essential Medicines, the most needed medicines in a health care system.

Media

If you are a member of the media and want to learn more about Phyton Biotech, please contact: [email protected]. We have English, Mandarin and German-speaking spokespersons.